nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.218	0.286	CbGbCtD
Latanoprost—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.212	0.277	CbGbCtD
Latanoprost—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.192	0.251	CbGbCtD
Latanoprost—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.142	0.186	CbGbCtD
Latanoprost—Toxic epidermal necrolysis—Nevirapine—acquired immunodeficiency syndrome	0.00142	0.00604	CcSEcCtD
Latanoprost—Dry eye—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.00602	CcSEcCtD
Latanoprost—Inflammation—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00598	CcSEcCtD
Latanoprost—Eye pain—Indinavir—acquired immunodeficiency syndrome	0.00136	0.00579	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Abacavir—acquired immunodeficiency syndrome	0.00135	0.00574	CcSEcCtD
Latanoprost—Inflammation—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.0057	CcSEcCtD
Latanoprost—Photophobia—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00566	CcSEcCtD
Latanoprost—Connective tissue disorder—Amprenavir—acquired immunodeficiency syndrome	0.00131	0.00556	CcSEcCtD
Latanoprost—Eczema—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.0055	CcSEcCtD
Latanoprost—Bronchitis—Stavudine—acquired immunodeficiency syndrome	0.00127	0.00538	CcSEcCtD
Latanoprost—Dry eye—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00536	CcSEcCtD
Latanoprost—Bronchitis—Abacavir—acquired immunodeficiency syndrome	0.00125	0.0053	CcSEcCtD
Latanoprost—Photophobia—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00519	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00506	CcSEcCtD
Latanoprost—Conjunctivitis—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00502	CcSEcCtD
Latanoprost—Diplopia—Efavirenz—acquired immunodeficiency syndrome	0.00116	0.00494	CcSEcCtD
Latanoprost—Eczema—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00487	CcSEcCtD
Latanoprost—Urinary tract infection—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00485	CcSEcCtD
Latanoprost—Conjunctivitis—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00485	CcSEcCtD
Latanoprost—Eye pain—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00484	CcSEcCtD
Latanoprost—Conjunctivitis—Abacavir—acquired immunodeficiency syndrome	0.00112	0.00478	CcSEcCtD
Latanoprost—Diplopia—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00473	CcSEcCtD
Latanoprost—Eczema—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00468	CcSEcCtD
Latanoprost—Connective tissue disorder—Nevirapine—acquired immunodeficiency syndrome	0.00107	0.00456	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00445	CcSEcCtD
Latanoprost—Connective tissue disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00441	CcSEcCtD
Latanoprost—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.00104	0.0044	CcSEcCtD
Latanoprost—Connective tissue disorder—Stavudine—acquired immunodeficiency syndrome	0.00104	0.0044	CcSEcCtD
Latanoprost—Diplopia—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00437	CcSEcCtD
Latanoprost—Connective tissue disorder—Abacavir—acquired immunodeficiency syndrome	0.00102	0.00433	CcSEcCtD
Latanoprost—Asthma—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00427	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Delavirdine—acquired immunodeficiency syndrome	0.001	0.00426	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Indinavir—acquired immunodeficiency syndrome	0.00099	0.0042	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.000981	0.00416	CcSEcCtD
Latanoprost—Discomfort—Amprenavir—acquired immunodeficiency syndrome	0.000976	0.00414	CcSEcCtD
Latanoprost—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.000951	0.00404	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Efavirenz—acquired immunodeficiency syndrome	0.000935	0.00397	CcSEcCtD
Latanoprost—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.000928	0.00394	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Ritonavir—acquired immunodeficiency syndrome	0.000927	0.00394	CcSEcCtD
Latanoprost—Bronchitis—Delavirdine—acquired immunodeficiency syndrome	0.000926	0.00393	CcSEcCtD
Latanoprost—Urinary tract infection—Indinavir—acquired immunodeficiency syndrome	0.000923	0.00392	CcSEcCtD
Latanoprost—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.000921	0.00391	CcSEcCtD
Latanoprost—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.000919	0.0039	CcSEcCtD
Latanoprost—Connective tissue disorder—Zidovudine—acquired immunodeficiency syndrome	0.000901	0.00382	CcSEcCtD
Latanoprost—Arthralgia—Didanosine—acquired immunodeficiency syndrome	0.0009	0.00382	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Delavirdine—acquired immunodeficiency syndrome	0.000895	0.0038	CcSEcCtD
Latanoprost—Back pain—Nelfinavir—acquired immunodeficiency syndrome	0.000891	0.00378	CcSEcCtD
Latanoprost—Asthma—Ritonavir—acquired immunodeficiency syndrome	0.00089	0.00378	CcSEcCtD
Latanoprost—Discomfort—Didanosine—acquired immunodeficiency syndrome	0.000889	0.00378	CcSEcCtD
Latanoprost—Back pain—Stavudine—acquired immunodeficiency syndrome	0.000888	0.00377	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.000862	0.00366	CcSEcCtD
Latanoprost—Asthma—Saquinavir—acquired immunodeficiency syndrome	0.000857	0.00364	CcSEcCtD
Latanoprost—Bronchitis—Ritonavir—acquired immunodeficiency syndrome	0.000856	0.00363	CcSEcCtD
Latanoprost—Connective tissue disorder—Indinavir—acquired immunodeficiency syndrome	0.000838	0.00356	CcSEcCtD
Latanoprost—Urinary tract infection—Delavirdine—acquired immunodeficiency syndrome	0.000834	0.00354	CcSEcCtD
Latanoprost—Conjunctivitis—Delavirdine—acquired immunodeficiency syndrome	0.000834	0.00354	CcSEcCtD
Latanoprost—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000826	0.00351	CcSEcCtD
Latanoprost—Bronchitis—Saquinavir—acquired immunodeficiency syndrome	0.000824	0.0035	CcSEcCtD
Latanoprost—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.000809	0.00344	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.000804	0.00341	CcSEcCtD
Latanoprost—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.0008	0.0034	CcSEcCtD
Latanoprost—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000798	0.00339	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.000796	0.00338	CcSEcCtD
Latanoprost—Connective tissue disorder—Efavirenz—acquired immunodeficiency syndrome	0.000791	0.00336	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.000786	0.00334	CcSEcCtD
Latanoprost—Bronchitis—Lamivudine—acquired immunodeficiency syndrome	0.000786	0.00334	CcSEcCtD
Latanoprost—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.000784	0.00333	CcSEcCtD
Latanoprost—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000781	0.00332	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000778	0.00331	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000776	0.00329	CcSEcCtD
Latanoprost—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000776	0.00329	CcSEcCtD
Latanoprost—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000774	0.00329	CcSEcCtD
Latanoprost—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.000772	0.00328	CcSEcCtD
Latanoprost—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.000771	0.00328	CcSEcCtD
Latanoprost—Conjunctivitis—Ritonavir—acquired immunodeficiency syndrome	0.000771	0.00328	CcSEcCtD
Latanoprost—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.00077	0.00327	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000765	0.00325	CcSEcCtD
Latanoprost—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000761	0.00323	CcSEcCtD
Latanoprost—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.000761	0.00323	CcSEcCtD
Latanoprost—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000754	0.0032	CcSEcCtD
Latanoprost—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.000751	0.00319	CcSEcCtD
Latanoprost—Conjunctivitis—Saquinavir—acquired immunodeficiency syndrome	0.000743	0.00315	CcSEcCtD
Latanoprost—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.000743	0.00315	CcSEcCtD
Latanoprost—Oedema—Abacavir—acquired immunodeficiency syndrome	0.000738	0.00313	CcSEcCtD
Latanoprost—Pain—Didanosine—acquired immunodeficiency syndrome	0.000738	0.00313	CcSEcCtD
Latanoprost—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000735	0.00312	CcSEcCtD
Latanoprost—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00073	0.0031	CcSEcCtD
Latanoprost—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000728	0.00309	CcSEcCtD
Latanoprost—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000726	0.00308	CcSEcCtD
Latanoprost—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000724	0.00307	CcSEcCtD
Latanoprost—Back pain—Indinavir—acquired immunodeficiency syndrome	0.000718	0.00305	CcSEcCtD
Latanoprost—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000717	0.00304	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000707	0.003	CcSEcCtD
Latanoprost—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000701	0.00298	CcSEcCtD
Latanoprost—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.0007	0.00297	CcSEcCtD
Latanoprost—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000699	0.00297	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000685	0.00291	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000682	0.0029	CcSEcCtD
Latanoprost—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000679	0.00288	CcSEcCtD
Latanoprost—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000679	0.00288	CcSEcCtD
Latanoprost—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000678	0.00288	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000675	0.00286	CcSEcCtD
Latanoprost—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000674	0.00286	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000672	0.00285	CcSEcCtD
Latanoprost—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000671	0.00285	CcSEcCtD
Latanoprost—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000671	0.00285	CcSEcCtD
Latanoprost—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00067	0.00284	CcSEcCtD
Latanoprost—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00067	0.00284	CcSEcCtD
Latanoprost—Pain—Nevirapine—acquired immunodeficiency syndrome	0.000663	0.00282	CcSEcCtD
Latanoprost—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000661	0.0028	CcSEcCtD
Latanoprost—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000658	0.00279	CcSEcCtD
Latanoprost—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000651	0.00276	CcSEcCtD
Latanoprost—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000649	0.00275	CcSEcCtD
Latanoprost—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000643	0.00273	CcSEcCtD
Latanoprost—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000643	0.00273	CcSEcCtD
Latanoprost—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000642	0.00273	CcSEcCtD
Latanoprost—Pain—Stavudine—acquired immunodeficiency syndrome	0.000641	0.00272	CcSEcCtD
Latanoprost—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000639	0.00271	CcSEcCtD
Latanoprost—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000632	0.00269	CcSEcCtD
Latanoprost—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000632	0.00268	CcSEcCtD
Latanoprost—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000632	0.00268	CcSEcCtD
Latanoprost—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000632	0.00268	CcSEcCtD
Latanoprost—Pain—Abacavir—acquired immunodeficiency syndrome	0.000631	0.00268	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000627	0.00266	CcSEcCtD
Latanoprost—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000624	0.00265	CcSEcCtD
Latanoprost—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000618	0.00262	CcSEcCtD
Latanoprost—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00061	0.00259	CcSEcCtD
Latanoprost—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000606	0.00257	CcSEcCtD
Latanoprost—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.0006	0.00255	CcSEcCtD
Latanoprost—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000597	0.00253	CcSEcCtD
Latanoprost—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000597	0.00253	CcSEcCtD
Latanoprost—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000597	0.00253	CcSEcCtD
Latanoprost—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000597	0.00253	CcSEcCtD
Latanoprost—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000596	0.00253	CcSEcCtD
Latanoprost—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000594	0.00252	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000593	0.00252	CcSEcCtD
Latanoprost—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000593	0.00252	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000593	0.00252	CcSEcCtD
Latanoprost—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00059	0.0025	CcSEcCtD
Latanoprost—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.0025	CcSEcCtD
Latanoprost—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000588	0.0025	CcSEcCtD
Latanoprost—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000585	0.00248	CcSEcCtD
Latanoprost—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00058	0.00246	CcSEcCtD
Latanoprost—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000577	0.00245	CcSEcCtD
Latanoprost—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000571	0.00242	CcSEcCtD
Latanoprost—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000571	0.00242	CcSEcCtD
Latanoprost—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000569	0.00242	CcSEcCtD
Latanoprost—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000564	0.0024	CcSEcCtD
Latanoprost—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000561	0.00238	CcSEcCtD
Latanoprost—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000557	0.00236	CcSEcCtD
Latanoprost—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000556	0.00236	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000552	0.00234	CcSEcCtD
Latanoprost—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000551	0.00234	CcSEcCtD
Latanoprost—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000549	0.00233	CcSEcCtD
Latanoprost—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000547	0.00232	CcSEcCtD
Latanoprost—Rash—Didanosine—acquired immunodeficiency syndrome	0.000544	0.00231	CcSEcCtD
Latanoprost—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000544	0.00231	CcSEcCtD
Latanoprost—Headache—Didanosine—acquired immunodeficiency syndrome	0.000541	0.0023	CcSEcCtD
Latanoprost—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00054	0.00229	CcSEcCtD
Latanoprost—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000532	0.00226	CcSEcCtD
Latanoprost—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000532	0.00226	CcSEcCtD
Latanoprost—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00053	0.00225	CcSEcCtD
Latanoprost—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.00224	CcSEcCtD
Latanoprost—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.00224	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000524	0.00223	CcSEcCtD
Latanoprost—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000522	0.00222	CcSEcCtD
Latanoprost—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.00222	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000521	0.00221	CcSEcCtD
Latanoprost—Pain—Indinavir—acquired immunodeficiency syndrome	0.000518	0.0022	CcSEcCtD
Latanoprost—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00051	0.00217	CcSEcCtD
Latanoprost—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.00216	CcSEcCtD
Latanoprost—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.00216	CcSEcCtD
Latanoprost—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000506	0.00215	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000505	0.00214	CcSEcCtD
Latanoprost—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.00213	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000499	0.00212	CcSEcCtD
Latanoprost—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000497	0.00211	CcSEcCtD
Latanoprost—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000496	0.00211	CcSEcCtD
Latanoprost—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000495	0.0021	CcSEcCtD
Latanoprost—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000492	0.00209	CcSEcCtD
Latanoprost—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000489	0.00208	CcSEcCtD
Latanoprost—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000489	0.00208	CcSEcCtD
Latanoprost—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000489	0.00208	CcSEcCtD
Latanoprost—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000488	0.00207	CcSEcCtD
Latanoprost—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000488	0.00207	CcSEcCtD
Latanoprost—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000487	0.00207	CcSEcCtD
Latanoprost—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000486	0.00206	CcSEcCtD
Latanoprost—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.00206	CcSEcCtD
Latanoprost—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.00206	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000482	0.00204	CcSEcCtD
Latanoprost—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000479	0.00203	CcSEcCtD
Latanoprost—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000478	0.00203	CcSEcCtD
Latanoprost—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000474	0.00201	CcSEcCtD
Latanoprost—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000473	0.00201	CcSEcCtD
Latanoprost—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000473	0.00201	CcSEcCtD
Latanoprost—Rash—Stavudine—acquired immunodeficiency syndrome	0.000472	0.00201	CcSEcCtD
Latanoprost—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000472	0.002	CcSEcCtD
Latanoprost—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000471	0.002	CcSEcCtD
Latanoprost—Headache—Stavudine—acquired immunodeficiency syndrome	0.000469	0.00199	CcSEcCtD
Latanoprost—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000468	0.00199	CcSEcCtD
Latanoprost—Rash—Abacavir—acquired immunodeficiency syndrome	0.000465	0.00198	CcSEcCtD
Latanoprost—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000465	0.00197	CcSEcCtD
Latanoprost—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000465	0.00197	CcSEcCtD
Latanoprost—Headache—Abacavir—acquired immunodeficiency syndrome	0.000462	0.00196	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000461	0.00196	CcSEcCtD
Latanoprost—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000461	0.00196	CcSEcCtD
Latanoprost—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000456	0.00194	CcSEcCtD
Latanoprost—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000451	0.00192	CcSEcCtD
Latanoprost—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000451	0.00192	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000444	0.00188	CcSEcCtD
Latanoprost—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000434	0.00184	CcSEcCtD
Latanoprost—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.00184	CcSEcCtD
Latanoprost—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000431	0.00183	CcSEcCtD
Latanoprost—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000428	0.00182	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000423	0.0018	CcSEcCtD
Latanoprost—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00177	CcSEcCtD
Latanoprost—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000414	0.00176	CcSEcCtD
Latanoprost—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000411	0.00174	CcSEcCtD
Latanoprost—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00041	0.00174	CcSEcCtD
Latanoprost—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000408	0.00173	CcSEcCtD
Latanoprost—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000405	0.00172	CcSEcCtD
Latanoprost—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.0004	0.0017	CcSEcCtD
Latanoprost—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000397	0.00169	CcSEcCtD
Latanoprost—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000387	0.00164	CcSEcCtD
Latanoprost—Rash—Indinavir—acquired immunodeficiency syndrome	0.000382	0.00162	CcSEcCtD
Latanoprost—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000381	0.00162	CcSEcCtD
Latanoprost—Headache—Indinavir—acquired immunodeficiency syndrome	0.000379	0.00161	CcSEcCtD
Latanoprost—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000378	0.00161	CcSEcCtD
Latanoprost—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.00154	CcSEcCtD
Latanoprost—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000361	0.00153	CcSEcCtD
Latanoprost—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00036	0.00153	CcSEcCtD
Latanoprost—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000358	0.00152	CcSEcCtD
Latanoprost—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000358	0.00152	CcSEcCtD
Latanoprost—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000345	0.00147	CcSEcCtD
Latanoprost—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000345	0.00146	CcSEcCtD
Latanoprost—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.00146	CcSEcCtD
Latanoprost—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000343	0.00146	CcSEcCtD
Latanoprost—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.00142	CcSEcCtD
Latanoprost—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.0014	CcSEcCtD
Latanoprost—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.00137	CcSEcCtD
Latanoprost—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00136	CcSEcCtD
Latanoprost—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00135	CcSEcCtD
Latanoprost—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000317	0.00135	CcSEcCtD
Latanoprost—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.0013	CcSEcCtD
Latanoprost—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.0013	CcSEcCtD
Latanoprost—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.0013	CcSEcCtD
Latanoprost—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000305	0.0013	CcSEcCtD
Latanoprost—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.00124	CcSEcCtD
Latanoprost—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.00124	CcSEcCtD
Latanoprost—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000291	0.00124	CcSEcCtD
